Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
Alexandru D. Buhimschi, Haley A. Armstrong, Momar Toure, et al.
Biochemistry (2018) Vol. 57, Iss. 26, pp. 3564-3575
Closed Access | Times Cited: 316

Showing 1-25 of 316 citing articles:

PROTAC targeted protein degraders: the past is prologue
Miklós Békés, David R. Langley, Craig M. Crews
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 181-200
Open Access | Times Cited: 1856
Targeted protein degradation: expanding the toolbox
Matthieu Schapira, Matthew F. Calabrese, Alex N. Bullock, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 12, pp. 949-963
Closed Access | Times Cited: 718
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Mariell Pettersson, Craig M. Crews
Drug Discovery Today Technologies (2019) Vol. 31, pp. 15-27
Open Access | Times Cited: 601
PROTACs: great opportunities for academia and industry
Xiuyun Sun, Hongying Gao, Yiqing Yang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 513
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva, Craig M. Crews
Current Opinion in Chemical Biology (2019) Vol. 50, pp. 111-119
Open Access | Times Cited: 481
PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 425
Targeted protein degradation: mechanisms, strategies and application
Lin Zhao, Jia Zhao, Kunhong Zhong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 420
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha, Craig M. Crews
Cell chemical biology (2020) Vol. 27, Iss. 8, pp. 998-1014
Open Access | Times Cited: 335
Protein degraders enter the clinic — a new approach to cancer therapy
Deborah Chirnomas, Keith R. Hornberger, Craig M. Crews
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 265-278
Closed Access | Times Cited: 335
Challenges and Opportunities in Cancer Drug Resistance
Richard A. Ward, Stephen E. Fawell, Nicolas Floc’h, et al.
Chemical Reviews (2020) Vol. 121, Iss. 6, pp. 3297-3351
Closed Access | Times Cited: 334
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 329
Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
Scott D. Edmondson, Bin Yang, Charlene Fallan
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 13, pp. 1555-1564
Closed Access | Times Cited: 318
Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
Sainan An, Liwu Fu
EBioMedicine (2018) Vol. 36, pp. 553-562
Open Access | Times Cited: 303
MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
John Hines, Schan Lartigue, Hanqing Dong, et al.
Cancer Research (2018) Vol. 79, Iss. 1, pp. 251-262
Open Access | Times Cited: 278
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 260
Degradation of proteins by PROTACs and other strategies
Yang Wang, Xueyang Jiang, Feng Feng, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 2, pp. 207-238
Open Access | Times Cited: 255
Light-Induced Protein Degradation with Photocaged PROTACs
Gang Xue, Kun Wang, Danli Zhou, et al.
Journal of the American Chemical Society (2019) Vol. 141, Iss. 46, pp. 18370-18374
Closed Access | Times Cited: 254
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng, Yuan Xiong, Nozhat Safaee, et al.
Cell chemical biology (2019) Vol. 27, Iss. 1, pp. 19-31.e6
Open Access | Times Cited: 239
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
Patrick Pfaff, Kusal T. G. Samarasinghe, Craig M. Crews, et al.
ACS Central Science (2019) Vol. 5, Iss. 10, pp. 1682-1690
Open Access | Times Cited: 229
PHOTACs enable optical control of protein degradation
Martin Reynders, Bryan S. Matsuura, Marleen Bérouti, et al.
Science Advances (2020) Vol. 6, Iss. 8
Open Access | Times Cited: 227
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan, Yonghan He, Xuan Zhang, et al.
Oncogene (2020) Vol. 39, Iss. 26, pp. 4909-4924
Open Access | Times Cited: 189
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 189
Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe, Craig M. Crews
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 934-951
Open Access | Times Cited: 186
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
Ming He, Chao-Guo Cao, Zhihao Ni, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 172
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Rati Verma, Dane Mohl, Raymond J. Deshaies
Molecular Cell (2020) Vol. 77, Iss. 3, pp. 446-460
Open Access | Times Cited: 171
Page 1 - Next Page

Scroll to top